Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors
- 1 March 2005
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (5), 1429-1433
- https://doi.org/10.1016/j.bmcl.2004.12.079
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Discovery of the Pyrrolo[2,1-f][1,2,4]triazine Nucleus as a New Kinase Inhibitor TemplateJournal of Medicinal Chemistry, 2004
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal CancerNew England Journal of Medicine, 2003
- The protein tyrosine kinase family of the human genomeOncogene, 2000
- Angiogenesis in cancer and other diseasesNature, 2000
- Binding Mode of the 4-Anilinoquinazoline Class of Protein Kinase Inhibitor: X-ray Crystallographic Studies of 4-Anilinoquinazolines Bound to Cyclin-Dependent Kinase 2 and p38 KinaseJournal of Medicinal Chemistry, 1999
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues.JCI Insight, 1992
- O-Diphenylphosphinylhydroxylamin (DPH), ein elektrophilesN-AminierungsmittelSynthesis, 1982
- Synthesis of amino acids and related compounds. 7. Convenient synthesis of 3-substituted pyrrole-2,4-dicarboxylic acid estersThe Journal of Organic Chemistry, 1974